Rizatriptan Benzoate

CAS: 145202-66-0

Ref. IN-DA00HXEE

Informação sobre produto

• Nome: Rizatriptan Benzoate
• Sinónimos: [u'L 705,126', u'L 705126', u'L-705,126', u'L-705126', u'Maxalt', u'MK 0462', u'MK 462', u'MK-0462', u'MK-462', u'N,N-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1H-indole-3-yl)ethylamine', u'rizatriptan', u'145202-66-0', u'Maxalt', u'Maxalt-MLT', u'MK-462', u'MK 462', u'MK-0462', u'UNII-WR978S7QHH', u'MK 0462', u'Rizatriptan benzoate [USAN:USP]', u'2-(5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-1H-INDOL-3-YL)-N,N-DIMETHYLETHANAMINE BENZOATE', u'L 705126', u'L-705126', u'WR978S7QHH', u'L 705,126', u'L-705,126', u'N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate', u'Rizatriptan Benzoate (Maxalt)', u'AK163196', u'1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, monobenzoate', u'3-(2-(Dimethylamino)ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate', u'benzoic acid; N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine', u'Rizatriptan Benzoate [USAN]', u'benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine', u'Rizatriptan(RIZ)', u'C15H19N5.C7H6O2', u'rizatrimptan benzoate', u'rizatriptane benzoate', u'MK-462 Benzoate', u'benzoic acid; rizatriptan', u'MK-462;Maxalt;Maxalt', u'AC1L2U9K', u'Rizatriptan-Benzoate(Maxalt)', u'SCHEMBL41226', u'MLS001424197', u'Rizatriptan Benzoate(Maxalt)/', u'CHEBI:8875', u'CHEMBL1201032', u'KS-00000XKR', u'DTXSID20162937', u'RHB-103', u'JPRXYLQNJJVCMZ-UHFFFAOYSA-N', u'Rizatriptan benzoate (JAN/USAN)', u'HMS2051B16', u'HMS2093K08', u'HMS2235M18', u'HMS3369I15', u'HMS3393B16', u'HMS3655K09', u'HMS3715D08', u'Pharmakon1600-01505189', u'ACT04340', u'BCP02149', u'HY-B0206', u'INT-0008', u'ABP000203', u'AC-734', u'BG0594', u'MFCD00866224', u'NSC758919', u'AKOS015855933', u'N,N-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1H-indole-3-yl)ethylamine', u'AB07521', u'API0004087', u'CCG-101039', u'CS-2147', u'KS-1189', u'NC00289', u'NSC-758919', u'RL01822', u'AN-15582', u'BC208268', u'CPD000525252', u'SAM001246615', u'SMR000525252', u'AB0011227', u'AB2000157', u'AX8006648', u'LS-173238', u'Rizatriptan benzoate salt, >=98% (HPLC)', u'FT-0631171', u'R0107', u'R0181', u'S1607', u'ST24039483', u'SW197669-2', u'D00675', u'X-2040', u'202R660', u'SR-01000763588', u'I01-0305', u'J-008071', u'J-524222', u'SR-01000763588-3', u'Rizatriptan benzoate, European Pharmacopoeia (EP) Reference Standard', u'Rizatriptan benzoate, United States Pharmacopeia (USP) Reference Standard', u'1H-Indole-3-ehtanamine,N,N-dimehtyl-5-(1H-1,2,4-triazol-1-ylmethyl)-,monobenzoate', u'2-(5-((1H-1,2,4-triazol-1-yl)methyl)-1H-indol-3-yl)-N,N-dimethylethan-1-amine benzoate', u'DIMETHYL-[2-(5-[1,2,4]TRIAZOL-1-YLMETHYL-1H-INDOL-3-YL)-ETHYL]-AMINE BENZOATE', u'N,N-DIMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOLE-3-ETHANAMINE BENZOATE', u'Rizatriptan for system suitability, European Pharmacopoeia (EP) Reference Standard', u'benzoic acid2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-N,N-bis(trideuteriomethyl)ethanamine', u'rizatriptan', u'Rizatriptanbenzoate', u'Rizatriptan Bezoate', u'Maxalt (TN)', u'RIZATRIPTAN MONOBENZOATE', u'C22H25N5O2', u'CID77997', u'Rizatriptan benzoate, 99% - 1G 1g', u'ACN-048281', u'CS-O-02233', u'C15-H19-N5.C7-H6-O2', u'A8516', u'C093622'], Rizatriptan benzoate, MK 462, Maxalt, 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, monobenzoate, 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, benzoate (1:1)
• Marca: Indagoo

Propriedades químicas

• Peso molecular: 391.4662
• Fórmula: C₂₂H₂₅N₅O₂
• Pureza: 98%+
• Cor/forma: Solid
• InChI: InChI=1S/C15H19N5.C7H6O2/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20;8-7(9)6-4-2-1-3-5-6/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3;1-5H,(H,8,9)
• Chave InChI: JPRXYLQNJJVCMZ-UHFFFAOYSA-N